UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $580,207 | +198.9% | 86,469 | +410.6% | 0.00% | – |
| Q2 2023 | $194,086 | -94.8% | 16,936 | -90.8% | 0.00% | -100.0% |
| Q1 2023 | $3,716,877 | +31.8% | 184,552 | +48.4% | 0.00% | +100.0% |
| Q4 2022 | $2,819,875 | +209.2% | 124,388 | +155.6% | 0.00% | – |
| Q3 2022 | $912,000 | -31.4% | 48,658 | -31.8% | 0.00% | -100.0% |
| Q2 2022 | $1,330,000 | -65.0% | 71,386 | -66.0% | 0.00% | 0.0% |
| Q1 2022 | $3,798,000 | +24.0% | 210,180 | +42.4% | 0.00% | 0.0% |
| Q4 2021 | $3,062,000 | +104.3% | 147,629 | +215.1% | 0.00% | – |
| Q3 2021 | $1,499,000 | +41.1% | 46,852 | +36.0% | 0.00% | – |
| Q2 2021 | $1,062,000 | -57.3% | 34,460 | -53.3% | 0.00% | -100.0% |
| Q1 2021 | $2,486,000 | +261.3% | 73,770 | +286.9% | 0.00% | – |
| Q4 2020 | $688,000 | -58.0% | 19,065 | -57.1% | 0.00% | -100.0% |
| Q3 2020 | $1,637,000 | +16.5% | 44,454 | +42.5% | 0.00% | – |
| Q2 2020 | $1,405,000 | -27.6% | 31,202 | -23.7% | 0.00% | -100.0% |
| Q1 2020 | $1,940,000 | -13.1% | 40,887 | +31.3% | 0.00% | 0.0% |
| Q4 2019 | $2,232,000 | +143.4% | 31,146 | +33.8% | 0.00% | – |
| Q3 2019 | $917,000 | -50.6% | 23,273 | -2.1% | 0.00% | -100.0% |
| Q2 2019 | $1,857,000 | +1558.0% | 23,765 | +1173.6% | 0.00% | – |
| Q1 2019 | $112,000 | +55.6% | 1,866 | -25.2% | 0.00% | – |
| Q4 2018 | $72,000 | -81.5% | 2,496 | -76.7% | 0.00% | – |
| Q3 2018 | $389,000 | -44.4% | 10,696 | -42.3% | 0.00% | – |
| Q2 2018 | $700,000 | +6263.6% | 18,531 | +3736.6% | 0.00% | – |
| Q1 2018 | $11,000 | -74.4% | 483 | -78.0% | 0.00% | – |
| Q4 2017 | $43,000 | -14.0% | 2,200 | -57.9% | 0.00% | – |
| Q3 2017 | $50,000 | +42.9% | 5,230 | -7.8% | 0.00% | – |
| Q2 2017 | $35,000 | +12.9% | 5,674 | +5.1% | 0.00% | – |
| Q1 2017 | $31,000 | -11.4% | 5,400 | -14.3% | 0.00% | – |
| Q4 2016 | $35,000 | 0.0% | 6,299 | +36.9% | 0.00% | – |
| Q3 2016 | $35,000 | +2.9% | 4,600 | 0.0% | 0.00% | – |
| Q2 2016 | $34,000 | -8.1% | 4,600 | +46.1% | 0.00% | – |
| Q1 2016 | $37,000 | +236.4% | 3,149 | +356.4% | 0.00% | – |
| Q4 2015 | $11,000 | +1000.0% | 690 | +1050.0% | 0.00% | – |
| Q3 2015 | $1,000 | -98.8% | 60 | -98.0% | 0.00% | – |
| Q2 2015 | $81,000 | +523.1% | 2,986 | +468.8% | 0.00% | – |
| Q1 2015 | $13,000 | – | 525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |